Adaptive Phage Therapeutics, Inc. — Form D/A

Adaptive Phage Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D amendment with the SEC on 2019-11-27. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Gregory MerrilDirectorNess Ziona, L3
Gregory MerrilExecutive OfficerNess Ziona, L3
Jonathan L LeffDirectorGaithersburg, MD
Jana L JensenDirectorGaithersburg, MD
Carl R MerrilDirectorGaithersburg, MD
Carl R MerrilExecutive OfficerGaithersburg, MD
Ian L HardyDirectorGaithersburg, MD
Michael L OrndorffExecutive OfficerGaithersburg, MD
Gregory L MerrilDirectorGaithersburg, MD
Gregory L MerrilExecutive OfficerGaithersburg, MD
Gregory L MerrilPromoterGaithersburg, MD
Jesse L GoodmanDirectorGaithersburg, MD
Raymond L MartzDirectorGaithersburg, MD
Martin L HeideckerDirectorGaithersburg, MD
Evan L LohDirectorGaithersburg, MD
Subhendu L BasuExecutive OfficerGaithersburg, MD
Subhendu Louis BasuExecutive OfficerGaithersburg, MD
Gregory Louis MerrilDirectorGaithersburg, MD
Gregory Louis MerrilExecutive OfficerGaithersburg, MD
Carl Louis MerrilDirectorGaithersburg, MD
Carl Louis MerrilExecutive OfficerGaithersburg, MD
Raymond Louis MartzDirectorGaithersburg, MD
William Louis MutrynDirectorGaithersburg, MD

Other filings by this issuer (7)

FiledFormOfferingSold
2023-06-09D$30.0M$12.0M
2021-05-20D$53.3M$23.3M
2020-08-27D/A$3.6M
2020-08-24D$7.0M$3.4M
2020-06-22D$7.0M$2.8M
2018-06-05D$5.0M$2.4M
2017-04-14D$3.0M$765K

More